Novocure
Ashley Cordova has served as Novocure’s Chief Financial Officer since September 2020. She is responsible for the oversight of Novocure’s global financial operations, including financial reporting, financial planning and analysis, treasury, tax, and investor relations.
From October 2018 to August 2020, Ms. Cordova served as the Company’s Senior Vice President, Finance and Investor Relations. Ms. Cordova joined the Company in June 2014 as Director of Global Treasury. In March 2015, she became the Company’s Senior Director, Investor Relations and Global Treasury, and in July 2016, she became the Company’s Vice President, Finance and Investor Relations. Prior to joining Novocure, Ms. Cordova served in various financial roles at Zoetis Inc. from 2012 to 2014 and Pfizer Inc. from 2005 to 2012. Ms. Cordova graduated with a bachelor’s degree in Music and Business from Furman University, and earned her International Master of Business Administration from the University of South Carolina.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.